Bard LifeStent and Lutonix DCB for Treatment of Long Lesions in Femoropopliteal Arteries

NCT02278991 · clinicaltrials.gov ↗
COMPLETED
Status
149
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

C. R. Bard